Physician
Muhammad Imtiaz, M.D.
According to 2025 Medicare claims, Muhammad Imtiaz, M.D. (NPI: 1639315435) practices pulmonary disease in the Binghamton, NY market, with the plurality of this provider's patient population coming from Broome, NY. This provider's primary affiliated billing organization is SOUTHERN TIER PULMONARY & CRITICAL CARE MEDICINE LLC (NPI: 1841303070; TIN: 205020595) and primary practice location at 13790-2107. Imtiaz is affiliated with the Keystone ACO (ACO ID: A1552) and AdvantagePoint Health Alliance - Laurel Highlands, LLC (ACO ID: A4657), participating under the MSSP model.
Imtiaz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 358 traditional Medicare patients, billed 1,169 HCPCS/CPT codes, and received $111,091 in Medicare payments. The top billing code was 99291 (Critical care, first 30-74 minutes). Part D data shows 1,899 prescription claims across 412 beneficiaries totaling $1,109,636 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 422 claims. Open Payments data shows 99 records totaling $2,633. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.
Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $43,165 and ending at $111,091. Concurrently, Part D prescription costs have risen steadily, from $35,719 to $1,109,636. In contrast, DME billing represents a smaller volume and rose steadily, from $1,010 to $27,238.